Skip to main content

Table 1 Baseline and characteristics

From: Heparin-binding protein measurement improves the prediction of myocardial injury-related cardiogenic shock

VariableControl
(n = 620)
MIRCS
(n = 172)
P value
Age (year)61.25 ± 13.1660.45 ± 8.940.45
Gender (male)282,45.48%85,49.42%0.39
Weight (kg)64.72 ± 11.8266.04 ± 14.230.22
Preoperative LVEF (%)49.96 ± 10.6050.45 ± 12.940.62
Preoperative LVDd (cm)5.78 ± 0.855.79 ± 1.170.91
Preoperative cTnT (ug/L)0.02 ± 0.020.02 ± 0.020.39
EuroSCORE4.82 ± 3.454.39 ± 3.290.13
Previous medical history
 Myocardial infarction3, 0.48%00.36
 Diabetes Mellitus (n,%)45,7.26%20,11.63%0.07
 Hypertension (n,%)336,54.19%79, 45.93%0.02
 Chronic Renal Failure (n,%)03,1.74%0.02
 Liver diseases (n,%)51, 8.23%13,7.56%0.75
 Previous cardiac operation (n,%)34,5.48%6, 3.49%0.27
 Immunological diseases (n,%)6, 0.97%00.19
 Atrial fibrillation (n,%)334, 53.87%68, 39.53%< 0.01
 Peripheral vascular diseases (n,%)13, 2.10%00.05
 Blood products transfusion (n,%)00
 Heavily smoking (n,%)72,11.61%0< 0.01
 Excessive alcohol (n,%)24, 3.87%3,1.74%0.24
Type of cardiac surgery (n,%)  0.02
 AVR21,3.39%0 
 MVR340, 54.84%82, 47.67% 
 AVR + MVR202, 32.58%69, 40.12% 
 Aortic operation + AVR57, 9.19%21, 12.21% 
Intraoperative AF ablation (n,%)306, 49.35%66, 38.37%0.01
CPB time (minutes)161.13 ± 74.83169.86 ± 51.570.08
ACC time (minutes)119.84 ± 65.42127.51 ± 46.440.09
  1. cTnT Serum cardiac troponin T, MVR Mitral valve replacement, MIRCS myocardial injury-related cardiogenic shock, CPB Cardiopulmonary Bypass, AVR Aortic valve replacement, LVEF Left Ventricular Ejection Fraction, LVDd Left ventricular end diastolic diameter